BioTrinity 2026

<p><!-- wp:paragraph --></p> <p><strong>Welcome to BioTrinity 2026, the 20th edition of OBN’s flagship two-day conference for the life sciences industry, designed to catalyse growth for all who attend. </strong></p> <p><!-- /wp:paragraph --></p> <p><!-- wp:paragraph --></p> <p>BioTrinity is attended by an ever-evolving international audience of c.850 delegates, comprising a mix of academic entrepreneurs, early stage and emerging life sciences R&D companies, funders & investors, big pharma teams, charities & research bodies, government, regulatory bodies, along with professional services and expert supporters to the industry. </p> <p><!-- /wp:paragraph --></p> <p><!-- wp:paragraph --></p> <p><strong>What’s New for 2026?</strong></p> <p><!-- /wp:paragraph --></p> <p><!-- wp:list --></p> <ul class="wp-block-list"><!-- wp:list-item --></p> <li>A showcase of 100 research updates ranging from Academic Posters to Pre-Seed, Seed, Series A R&D companies</li> <p><!-- /wp:list-item --></p> <p><!-- wp:list-item --></p> <li>A dedicated one-day session showcasing opportunities for growth in international markets</li> <p><!-- /wp:list-item --></p> <p><!-- wp:list-item --></p> <li>A new and much demanded ‘mentor match-making lunch’ for early stage Founders & CEOs to meet with those that can provide support and guidance.  </li> <p><!-- /wp:list-item --></p> <p><!-- wp:list-item --></p> <li>An increased Big Pharma presence</li> <p><!-- /wp:list-item --></p> <p><!-- wp:list-item --></p> <li>A focus on unlocking access to alternative sources of funding</li> <p><!-- /wp:list-item --></ul> <p><!-- /wp:list --></p> <p><!-- wp:paragraph --></p> <p>Keen to Attend, Sponsor or Support BioTrinity 2026? </p> <p><!-- /wp:paragraph --></p> <p><!-- wp:paragraph --></p> <p><a href="https://heyzine.com/flip-book/0fc49f0a75.html#page/1" target="_blank" rel="noreferrer noopener">View our opportunities document here</a></p> <p><!-- /wp:paragraph --></p>